Terminated PHASE2 INTERVENTIONAL 1-arm NCT01403259

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Phase II Study of SOX in Patients With Platinum-resistant Nasopharyngeal Carcinoma

Sponsor: Fudan University

Updated 5 times since 2017 Last updated: Aug 19, 2014 Started: Jul 31, 2011 Primary completion: Dec 31, 2014 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

poor accrual of eligible patients

Other terminated trials from Fudan University

See all terminations from Fudan University

Other Nasopharyngeal Carcinoma trials with similar outcome

Browse all Nasopharyngeal Carcinoma trials

This PHASE2 trial investigates Nasopharyngeal Carcinoma and is currently terminated or withdrawn. Fudan University leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fudan University

Data source: Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China